Virginia Commonwealth University researchers have collaborated on a clinical trial that identifies indicators for nonalcoholic fatty liver disease—a typically asymptomatic disease caused by fat buildup in the liver and ...
Nov 21, 2018
0
13
A condition involving excess fat buildup in the liver is grossly underdiagnosed in the United States, according to an analysis of Medicare claims data. The condition, called nonalcoholic fatty liver disease (NAFLD), is often ...
May 6, 2020
0
1
Gut hormones play an important role in regulating fat production in the body. One key hormone, released a few hours after eating, turns off fat production by regulating gene expression in the liver, but this regulation is ...
Nov 24, 2020
0
157
Severe fatty liver disease is commonly associated with obesity, but according to a review of scientific literature conducted by researchers at Temple University and the Translational Genomics Research Institute (TGen), an ...
Mar 24, 2022
0
77
A recently developed amino acid compound successfully treats nonalcoholic fatty liver disease in non-human primates—bringing scientists one step closer to the first human treatment for the condition that is rapidly increasing ...
Apr 10, 2023
0
190
Yale researchers have zeroed in on a molecular link between nonalcoholic fatty liver disease and liver insulin resistance in type 2 diabetes. The findings, reported Sept. 2 in the journal Cell Metabolism, will help pave the ...
Sep 2, 2020
0
98
A randomized clinical study of adolescent boys with nonalcoholic fatty liver disease (NAFLD) found that a diet low in free sugars (those sugars added to foods and beverages and occurring naturally in fruit juices) resulted ...
Jan 22, 2019
0
353
Caffeine consumption has long been associated with decreased risk of liver disease and reduced fibrosis in patients with chronic liver disease. Now, newly published research confirms that coffee caffeine consumption reduces ...
Feb 2, 2012
0
0
Gregory Ginsberg, a Penn Medicine doctor, is exploring a new frontier in the treatment of type 2 diabetes.
Jan 29, 2020
1
13
A team led by Michael Trauner at MedUni Vienna's Division of Gastroenterology and Hepatology demonstrated the beneficial effect of synthetically produced bile acid with the active agent nor-ursodeoxycholic acid (nor-urso) ...
Jul 29, 2019
0
2
